Paper34100716
Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy.
Uehara H and 16 others. Elife, 2021. Cited by 45 papers, by iCite.
Cite this record
ConductScience Library. Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy. Papers, record 34100716. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34100716
- Cell line
- NIH 3T3264 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CRISPR-Cas Systems | Major topic |
| Codon, Initiator | Major topic |
| Fuchs' Endothelial Dystrophy | Major topic |
| Gene Editing | Major topic |
| Animals | |
| Collagen Type VIII | |
| Disease Models, Animal | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| RNA, Guide, CRISPR-Cas Systems |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 EY017950 | NEI NIH HHS | United States | R01EY017950 | PubMed and NIH |
Source NIH RePORTER
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34100716 | Start codon disruption with CRISPR/Cas9 prevents murine Fuchs' endothelial corneal dystrophy. | Elife | 2021 | https://conductscience.org/library/papers/34100716 | PubMed |
| 2 | 28358029 | Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy. | Nat Commun | 2017 | https://conductscience.org/library/papers/28358029 | PubMed |
| 3 | 23422828 | L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23422828 | PubMed |
| 4 | 25322173 | Factors associated with corneal graft survival in the cornea donor study. | JAMA Ophthalmol | 2015 | https://conductscience.org/library/papers/25322173 | PubMed |
| 5 | 16051690 | Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. | FASEB J | 2005 | https://conductscience.org/library/papers/16051690 | PubMed |
| 6 | 22002996 | An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. | Hum Mol Genet | 2012 | https://conductscience.org/library/papers/22002996 | PubMed |
| 7 | 11157802 | Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13). | Hum Mol Genet | 2001 | https://conductscience.org/library/papers/11157802 | PubMed |
| 8 | 23110055 | Differing roles for TCF4 and COL8A2 in central corneal thickness and fuchs endothelial corneal dystrophy. | PLoS One | 2012 | https://conductscience.org/library/papers/23110055 | PubMed |
| 9 | 6700727 | Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo. | Nature | 1984 | https://conductscience.org/library/papers/6700727 | PubMed |
| 10 | 23287722 | RNA-guided human genome engineering via Cas9. | Science | 2013 | https://conductscience.org/library/papers/23287722 | PubMed |
| 11 | 11689488 | Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. | Hum Mol Genet | 2001 | https://conductscience.org/library/papers/11689488 | PubMed |
| 12 | 20036349 | Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. | Am J Hum Genet | 2010 | https://conductscience.org/library/papers/20036349 | PubMed |
| 13 | 22956607 | Endothelial Cdkn1a (p21) overexpression and accelerated senescence in a mouse model of Fuchs endothelial corneal dystrophy. | Invest Ophthalmol Vis Sci | 2012 | https://conductscience.org/library/papers/22956607 | PubMed |
| 14 | 22998502 | Confirmation of the association between the TCF4 risk allele and Fuchs endothelial corneal dystrophy in patients from the Midwestern United States. | Ophthalmic Genet | 2013 | https://conductscience.org/library/papers/22998502 | PubMed |
| 15 | 24763830 | Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty: survival, rejection risk, and visual outcome. | JAMA Ophthalmol | 2014 | https://conductscience.org/library/papers/24763830 | PubMed |
| 16 | 29966009 | Gene expression in the corneal endothelium of Fuchs endothelial corneal dystrophy patients with and without expansion of a trinucleotide repeat in TCF4. | PLoS One | 2018 | https://conductscience.org/library/papers/29966009 | PubMed |
| 17 | 17546019 | A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. | Nat Protoc | 2007 | https://conductscience.org/library/papers/17546019 | PubMed |
| 18 | 26937169 | Fuchs endothelial corneal dystrophy: current perspectives. | Clin Ophthalmol | 2016 | https://conductscience.org/library/papers/26937169 | PubMed |
| 19 | 31469403 | Gene Expression and Missplicing in the Corneal Endothelium of Patients With a TCF4 Trinucleotide Repeat Expansion Without Fuchs' Endothelial Corneal Dystrophy. | Invest Ophthalmol Vis Sci | 2019 | https://conductscience.org/library/papers/31469403 | PubMed |
| 20 | 22715153 | The KAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms. | Hum Mutat | 2012 | https://conductscience.org/library/papers/22715153 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930058 | Gene Therapy for Corneal Diseases. | BioTech (Basel) | 2026 | https://conductscience.org/library/papers/42930058 | PubMed |
| 42675489 | Targeting LRPPRC to improve corneal wound healing via augmenting autophagy and suppressing TGF-β/Smad signaling post-alkali burn. | J Transl Med | 2026 | https://conductscience.org/library/papers/42675489 | PubMed |
| 42627922 | RNA delivery to the corneal endothelium using charge-altering releasable transporters. | Sci Adv | 2026 | https://conductscience.org/library/papers/42627922 | PubMed |
| 42397667 | Association between subjective symptoms and severity in patients with Fuchs endothelial corneal dystrophy. | Jpn J Ophthalmol | 2026 | https://conductscience.org/library/papers/42397667 | PubMed |
| 42278622 | Contemporary Endothelial Genome Editing Technologies: Towards Precision Genetic Medicine for Vascular Diseases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278622 | PubMed |
| 41900769 | Anatomically Guided Non-Viral CRISPR/Cas9 Delivery in the Eye: Overcoming Barriers for Precision Gene Therapy. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41900769 | PubMed |
| 41850243 | Targeted AAV6 gene therapy restores corneal endothelial function in three hereditary corneal dystrophies. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41850243 | PubMed |
| 41820594 | Topical application of Cas9 ribonucleoproteins inhibits corneal neovascularization in a mouse model of alkali burn injury. | Gene Ther | 2026 | https://conductscience.org/library/papers/41820594 | PubMed |
| 41809205 | Congenital Hereditary Endothelial Dystrophy: A Review of the Molecular Pathogenesis, Genetic Basis, and Emerging Treatments. | Clin Ophthalmol | 2026 | https://conductscience.org/library/papers/41809205 | PubMed |
| 41658434 | Advances and challenges of CRISPR/Cas gene editing for corneal diseases. | Adv Ophthalmol Pract Res | 2026 | https://conductscience.org/library/papers/41658434 | PubMed |
| 41641337 | Type VIII collagen: advances in matrix biology and translational promise. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/41641337 | PubMed |
| 41328347 | Advancements in CRISPR-based therapies for ocular pathologies: from disease mechanisms to intervention strategies. | Theranostics | 2026 | https://conductscience.org/library/papers/41328347 | PubMed |
| 41283239 | Emerging Innovations in the Treatment of Fuchs Endothelial Corneal Dystrophy: A Narrative Review. | Med Sci (Basel) | 2025 | https://conductscience.org/library/papers/41283239 | PubMed |
| 41153439 | Genetic Therapy of Fuchs Endothelial Corneal Dystrophy: Where Are We? A Review. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/41153439 | PubMed |
| 40924317 | Correlation between visual function and corneal backscatter by Scheimpflug imaging or anterior segment optical coherence tomography in Fuchs endothelial corneal dystrophy. | Jpn J Ophthalmol | 2025 | https://conductscience.org/library/papers/40924317 | PubMed |
| 40650962 | Developing stem cells for corneal disease: recent developments and future perspectives. | Regen Med | 2025 | https://conductscience.org/library/papers/40650962 | PubMed |
| 40202733 | Iron-Sulfur Clusters and Iron Responsive Element Binding Proteins Mediate Iron Accumulation in Corneal Endothelial Cells in Fuchs Dystrophy. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40202733 | PubMed |
| 40002778 | Looking to the Future of Viral Vectors in Ocular Gene Therapy: Clinical Review. | Biomedicines | 2025 | https://conductscience.org/library/papers/40002778 | PubMed |
| 39952985 | Advancements in bioengineering for descemet membrane endothelial keratoplasty (DMEK). | NPJ Regen Med | 2025 | https://conductscience.org/library/papers/39952985 | PubMed |
| 39716183 | A tool for CRISPR-Cas9 sgRNA evaluation based on computational models of gene expression. | Genome Med | 2024 | https://conductscience.org/library/papers/39716183 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACAN | 176 | PubTator's text mining | https://conductscience.org/library/genes/176 | NCBI Gene |
| COL8A2 | 1296 | PubTator's text mining | https://conductscience.org/library/genes/1296 | NCBI Gene |
| KAT6B | 23522 | PubTator's text mining | https://conductscience.org/library/genes/23522 | NCBI Gene |
| LMO7 | 4008 | PubTator's text mining | https://conductscience.org/library/genes/4008 | NCBI Gene |
| SRGAP2 | 23380 | PubTator's text mining | https://conductscience.org/library/genes/23380 | NCBI Gene |
| SV2C | 22987 | PubTator's text mining | https://conductscience.org/library/genes/22987 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GEO | GSE146999 |
Source GEO
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34100716
GET https://conductscience.org/api/papers/v1/34100716/references?page=2